* 1. Please indicate your primary type of business:

* 2. What is the most effective way to reduce pharmaceutical costs (specialty and non-specialty)?

* 3. What is the biggest opportunity to reduce specialty pharmaceutical costs?

* 4. What is the best coverage strategy for new, innovative therapeutics and biologics?

* 5. Will biosimilars reduce specialty drug costs?

* 6. What will be the biggest driver of specialty drug costs in 2017?

* 7. How will performance-based pricing evolve over the next 3-5 years?

* 8. What is the best long-term approach to addressing the high cost of rare disease treatment?

* 9. Should pharmacists be compensated under Medicare Part B for prescribing medications and helping assess patient conditions?